Neurological complications during treatment of childhood cancer: mind Wernicke encephalopathy

Pediatr Hematol Oncol. 2010 May;27(4):320-3. doi: 10.3109/08880011003663408.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Asparaginase / administration & dosage
  • Asparaginase / adverse effects
  • Child
  • Cyclophosphamide / administration & dosage
  • Cyclophosphamide / adverse effects
  • Cytarabine / administration & dosage
  • Cytarabine / adverse effects
  • Daunorubicin / administration & dosage
  • Daunorubicin / adverse effects
  • Humans
  • Leukemia, Myeloid, Acute / diagnostic imaging
  • Leukemia, Myeloid, Acute / drug therapy*
  • Magnetic Resonance Imaging
  • Male
  • Mercaptopurine / administration & dosage
  • Mercaptopurine / adverse effects
  • Methotrexate / administration & dosage
  • Methotrexate / adverse effects
  • Prednisone / administration & dosage
  • Prednisone / adverse effects
  • Radiography
  • Vincristine / administration & dosage
  • Vincristine / adverse effects
  • Wernicke Encephalopathy / chemically induced*
  • Wernicke Encephalopathy / diagnostic imaging
  • Wernicke Encephalopathy / drug therapy

Substances

  • Cytarabine
  • Vincristine
  • Cyclophosphamide
  • Mercaptopurine
  • Asparaginase
  • Prednisone
  • Methotrexate
  • Daunorubicin

Supplementary concepts

  • AIEOP acute lymphoblastic leukemia protocol